SOME PERSPECTIVE RADIONUCLIDES IN THE NUCLEAR MEDICINE OF KAZAKHSTAN
https://doi.org/10.52676/1729-7885-2018-1-31-35
Abstract
It is necessary to replenish the kit of the domestic generator 99mTc with new reagents, which expand the possibilities of radionuclide examination of organs and systems. It should be possible to release an ideal diagnostic pair for therapeutic radiopharmaceuticals, such as 123I for less affordable 131I. Establishing the production and cardiomyotropic and parathyroid tropic radiopharmaceutical 201Tl is important. Scintigraphy is one of the most informative imaging techniques. 68Ge/68Ga generator in accordance with the term of operation for two years, provides cancer specific pharmaceutical to oncological clinics, which is an alternative to expensive cyclotron radionuclides.
About the Authors
I. Таzhеdinov
Kazakh Institute of Oncology and Radiology
Kazakhstan
Almaty
Kazakhstan
Almaty
Zh. Аmankulov
Kazakh Institute of Oncology and Radiology
Kazakhstan
Almaty
Kazakhstan
Almaty
U. K. Zhalmukash
Al-Farabi Kazakh National University
Kazakhstan
Almaty
Kazakhstan
Almaty
Sh. K. Hussain
Astana Medical University
Kazakhstan
Astana
Kazakhstan
Astana
O. G. Hаn
Kazakh Institute of Oncology and Radiology
Kazakhstan
Almaty
Kazakhstan
Almaty
References
1. Krylov V.V., Drozdovskiy B.Ya., Tsyb A.F. Radionuklidnaya terapiya v palliativnom lechenii bol'nykh metastazami v kosti (obzor literatury) Zh. Med. radiol. i radiats. bezopasnost', 2006, T. 51, No. 3, P. 48-54.
2. Tsyb A.F., Drozdovskiy B.Ya., Krylov V.V., Kodina G.E. Palliativnaya terapiya oksabiforom153Sm pri metastaticheskikh porazheniyakh kostey. Zh. Med.radiol. i radiats. bezopasnost', 2002, T. 47, No. 4, P. 37-42.
3. Markus L., Ralph F., Markus D., Christoph R. Thyroid Hormone Withdrawal in Patients with Differentiated Thyroid Carcinoma: A One Hundred Thirty- Patients Pilot Survey on Consequences of Hypothyroidism and a Pharmacoeconomic Comparison to Recombinant Thyrotropin Administration. THYROID. 2005, Vol. 15, No. 10, P. 1147-1155.
4. Furio P., Martin S., Clive H., Gertrud G.B., Ohad C. et al. Post-surgical use of radioiodine (131I) in patients With papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. European Journal of Endocrinology. 2005, 153, P. 651-659.
5. Rumyantsev P.O., Il'in A.A., Rumyantseva U.V., Saenko V.A. Rak shchitovidnoy zhelezy. //Sovremennye podkhody k diagnostike i lecheniyu. Moskva. Izdatel'skaya gruppa «GEOTAR-Media». 2009, P. 298-316.
6. Neal D. Dhore. Primenenie radiya-223 dikhlorida pri metastaticheskom kastratsionno-rezistentnom rake predstatel'noy zhelezy: tochka zreniya urologa. Perevod na russkom yazyke. UROLOGY. 85 (4), 2015, P. 717-728.
7. Gigienicheskie normativy «Sanitarno-epidemiologicheskie trebovaniya k obespecheniyu radiatsionnoy bezopasnosti» utverzhdennyy prikazom Ministerstva natsional'noy ekonomiki Respubliki Kazakhstan ot 27 fevralya 2015 goda No. 155. Prilozhenie 5. P.15.
8. Bogorodskaya M.A., Kodina G.E. //Khimicheskaya tekhnologiya radiofarmatsevticheskikh preparatov. Moscow: 2010, 461 p.
9. Gabuniya R.I. Primenenie tsitrata 67Ga v klinicheskoy onkologii. Zh. Med. radiol., 1980, T. 25, No. 1, P. 6-10.
10. Narkevich B.Ya., Kostylev V.A. Radionuklidnaya terapiya i ee fiziko-matematicheskoe obespechenie. Zh. Med. fizika, 2004, No. 2 (22), P. 64-71.
11. Narkevich B.Ya., Kostylev V.A., Glukhov S. B., Matsuka D.G., Levchuk A.V. Mediko-fizicheskie osnovy radionuklidnoy terapii. Uchebnoe posobie. Moskva, 2006, 60 p.
12. Klepov A.N., Kurachenko Yu.A., Levchenko V.A., Matusevich E.S. Primenenie metodov matematicheskogo modelirovaniya v yadernoy meditsine. Obninsk, 2006, 202 p.
13. Lipanova N.N., Klepov A.N., Narkevich B.Ya. Dozimetricheskoe planirovanie i dozovyy kontrol' v radioyodoterapii raka shchitovidnoy zhelezy. //Med.radiol i radiats. bezopasnost'. 2012, T. 57, No. 3, P. 53-65.
14. Lishmanov Yu.B., Chernov V.I. 2.4.1. Metody perfuzionnoy stsintigrafii serdtsa. Natsional'noe rukovodstvo po radionuklidnoy diagnostike. Pod redaktsiey Yu.B. Lishmanova, V.I. Chernova. Tomsk: STT. 2010, T. 2, P. 12-46.
15. Lishmanov Yu.B., Chernov V.I. Stsintigrafiya miokarda v yadernoy kardiologii. Izdatel'stvo Tomskogo universiteta. Tomsk. 1997, 273 p.
16. Efimov I.Yu. 2.9.2. Radionuklidnaya diagnostika parashchitovidnoy zhelezy. Natsional'noe rukovodstvo po radionuklidnoy diagnostike. Pod redaktsiey Yu.B. Lishmanova, V.I. Chernova. Tomsk: STT. 2010, T. 2, P. 282-286.
17. Parathyroid Scintigraphy. A Technologistʹs Guide. European Association of Nuclear Medicine. Sponsored Bristol-Myers Squibb Medical Imaging. Innovators at Heart. Austria, Venn, 2005, 43 p.
18. Freyman E.S., Shupanovskiy V.D., Kaloshin V.M. Osnovy bezopasnosti perevozki radioaktivnykh veshchestv. Moskva. Energoatomizdat. 1986, 176 p.
Review
For citations:
Таzhеdinov I., Аmankulov Zh., Zhalmukash U.K., Hussain Sh.K., Hаn O.G. SOME PERSPECTIVE RADIONUCLIDES IN THE NUCLEAR MEDICINE OF KAZAKHSTAN. NNC RK Bulletin. 2018;(1):31-35. (In Russ.) https://doi.org/10.52676/1729-7885-2018-1-31-35
Views:
285
Email this article 